CUSIP: 88907J107
Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,190,069
-
Share change
-
+879,883
-
Total reported value
-
$91,237,818
-
Price per share
-
$14.74
-
Number of holders
-
44
-
Value change
-
+$13,055,837
-
Number of buys
-
29
-
Number of sells
-
11
Quarterly Holders Quick Answers
What is CUSIP 88907J107?
CUSIP 88907J107 identifies TKAI - TOKAI PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2015
-
Previous quarter:
Q3 2014
Recent filing periods for CUSIP 88907J107:
Institutional Holders of TOKAI PHARMACEUTICALS INC - COM (TKAI) as of Q4 2014
As of 31 Dec 2014,
TOKAI PHARMACEUTICALS INC - COM (TKAI) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,190,069 shares.
The largest 10 holders included
Novo A/S, FMR LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., Tourbillon Capital Partners LP, PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, Alyeska Investment Group, L.P., Redmile Group, LLC, and JPMORGAN CHASE & CO.
This page lists
44
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.